Bacillus Calmette-Guérin in the Treatment of Tuberculosis and Bladder Cancer: Clinical Use and Immunologic Response. Reports of a workshop. Toronto, Canada, 11-13 July 1994.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001500:BCG Vaccine / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D023421:Models, Animal; D014376:Tuberculosis / Q000517:prevention & control*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine